Post-Conference Perspectives: Breast Cancer Recurrence Monitoring by ctDNA - Episode 1

Best Practices for Assessing Risk of Recurrence in Patients with Breast Cancer

Aditya Bardia, MD, MPH shares his approach to assessing breast cancer recurrence risk and monitoring patients during and after treatment.

Now Viewing
EP. 1: Best Practices for Assessing Risk of Recurrence in Patients with Breast Cancer
EP. 2: Clinical Evidence Supporting the use of ctDNA to Detect Recurrence
EP. 3: Data Review: ctDNA Monitoring in Patients with Breast Cancer
EP. 4: Practical Clinical Applications for ctDNA Assessment
EP. 5: Technical and Logistical Challenges Concerning the use of ctDNA Monitoring
EP. 6: Promising Strategies for Assessing Risk and Detecting Recurrence Earlier

Related Content:

Post-Conference Perspectives: Breast Cancer Recurrence Monitoring by ctDNAOncLive News Network®
Key Takeaways for Concurrent Biomarker Testing in NSCLC
Overcoming Barriers to NSCLC Biomarker Testing
Challenges of NSCLC Biomarker Testing in Clinical Practice